Robotic Surgery for the Treatment of Achalasia with Intraoperative Manometry: Case Report

Introduction: Achalasia, the Greek term meaning, is a disease of unknown cause in which there is a failure to relax the lower esophageal sphincter and loss of peristalsis in the distal esophagus. Achalasia was first described by Sir Thomas Willis in 1674. Clinical case: 63-year-old female with no significant history for the case. Upon admission, the patient presented dysphagia, reflux, aspiration, substernal pain, and weight loss. Endoscopy showed Schatzki ring; Type I hiatal hernia of 5 cm, grade D esophagitis (Los Angeles classification). Manometry showed an IRP -3.06; absent esophageal clearance, without evidence of hiatal hernia, with a diagnosis of probable achalasia. The SEGD presented an area of V stenosis and a Heller myotomy with Dor-type fundoplication was performed using robotic surgery. Discussion: In clinical practice, the combined use of esophagogastroduodenoscopy (EGD) and upper gastrointestinal series (SGD) helps to evaluate patients who present with dysphagia and/or regurgitation, which are the most common clinical findings in these patients. High-resolution esophageal manometry (HREM) has become an essential tool in the last decade to categorize types of esophageal achalasia with associated lack of relaxation of the lower esophageal sphincter. Current pharmacological, endoscopic and surgical treatment options aim to reduce the hypertonicity of the lower esophageal sphincter, but unfortunately, the absence of esophageal peristalsis does not restore it to normal propulsive waves. Pharmacological treatments, including calcium channel blockers or sequential injection of botulinum toxin, are usually limited to patients who are not amenable to surgical treatment and have limited effects.

Authors

Institutions

Publication Details

Journal
British journal of healthcare and medical research
Published
2025-05-26
DOI
https://doi.org/10.14738/bjhr.1203.17241
Citations
1
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
1.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Robotic Surgery for the Treatment of Achalasia with Intraoperative Manometry: Case Report

Teresa de Jesús Galicia-Gómez, Guillermo Padrón-Arredondo, Israel A. Gaytan-Fuentes, Omar Felipe Gaytán-Fuentes et al.
1 citations
British journal of healthcare and medical research
Gastroesophageal reflux and treatments
1.81
article

Robotic Surgery for the Treatment of Achalasia with Intraoperative Manometry: Case Report

Teresa de Jesús Galicia-Gómez, Guillermo Padrón-Arredondo, Israel A. Gaytan-Fuentes, Omar Felipe Gaytán-Fuentes, Jairo Arturo Barba-Mendoza, Ricardo Cerón-Castillo, Edith Barajas-Galicia
article en
1 citations

Abstract

Introduction: Achalasia, the Greek term meaning, is a disease of unknown cause in which there is a failure to relax the lower esophageal sphincter and loss of peristalsis in the distal esophagus. Achalasia was first described by Sir Thomas Willis in 1674. Clinical case: 63-year-old female with no significant history for the case. Upon admission, the patient presented dysphagia, reflux, aspiration, substernal pain, and weight loss. Endoscopy showed Schatzki ring; Type I hiatal hernia of 5 cm, grade D esophagitis (Los Angeles classification). Manometry showed an IRP -3.06; absent esophageal clearance, without evidence of hiatal hernia, with a diagnosis of probable achalasia. The SEGD presented an area of V stenosis and a Heller myotomy with Dor-type fundoplication was performed using robotic surgery. Discussion: In clinical practice, the combined use of esophagogastroduodenoscopy (EGD) and upper gastrointestinal series (SGD) helps to evaluate patients who present with dysphagia and/or regurgitation, which are the most common clinical findings in these patients. High-resolution esophageal manometry (HREM) has become an essential tool in the last decade to categorize types of esophageal achalasia with associated lack of relaxation of the lower esophageal sphincter. Current pharmacological, endoscopic and surgical treatment options aim to reduce the hypertonicity of the lower esophageal sphincter, but unfortunately, the absence of esophageal peristalsis does not restore it to normal propulsive waves. Pharmacological treatments, including calcium channel blockers or sequential injection of botulinum toxin, are usually limited to patients who are not amenable to surgical treatment and have limited effects.

British journal of healthcare and medical researchVol. 12(03)
Albert Einstein College of Medicine (US), Montefiore Medical Center (US), University of Quintana Roo (MX), Autonomous University of Yucatán (MX), Institute for Social Security and Services for State Workers (MX)
Openalex Percentile: Top 16%
Gastroesophageal reflux and treatments
1.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.